Sensex today | Stock Market Live: Stock to buy today: Crisil (₹4,496) – BUY

Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for July 23, 2026.

The short-term outlook is bullish for Crisil. The stock surged by more than 4 per cent on Wednesday, while the broader markets were beaten down. This rise has taken the share price well above the 200-Day Moving Average (DMA). It confirms a bottom formation and a bullish trend reversal.

Oil prices rose more than 1.5% to their highest in more than six weeks on Thursday, with the United States launching ⁠a new round of strikes on Iran and Yemen’s Houthis targeting oil tankers in the Red Sea.

Brent crude futures rose $1.93, or 2% to $96 by 0011 GMT, the highest ‌since June 8. It had settled over $3 higher at $94.07 in the previous session, just shy of a six-week high.

Revenue from operations for Q1 FY27 stood at Rs. 924.25 crores a growth of 53.23% YoY

Strong unexecuted orderbook of Rs. 5,300+ crores underpins sustained revenue visibility

EBITDA Margin 16.40% vs 15.75% YoY & 16.29% QoQ

Profit Up 68.2% At ₹1,416 Cr Vs ₹842 Cr (QoQ)

Revenue Up 51.3% At ₹3,125 Cr Vs ₹2,065 Cr (QoQ)

EBIT Up 29.5% At ₹1,862 Cr Vs ₹1,050 Cr (QoQ)

HFCL’s Board has approved setting up a state-of-the-art manufacturing facility for Data Center Connectivity Products with an annual capacity of 2.7 lakh assemblies at an estimated capital outlay of ₹215 crore. 

• The investment is driven by the surging global demand for AI, hyperscale data centres, cloud computing, high-performance computing and high-speed networking, creating significant business opportunities in domestic and international markets. 

* The facility will manufacture Miniature Multi-Fiber (MMC) and Super High-Density Multi-Fiber Termination (SNMT) assemblies used in high-speed data centres and AI infrastructure and is expected to be commissioned by September 2027.

Headline results: Continuingrevenue, EBITDA, and PAT growth of +28%, +40% and +42% was +18%, +25%, and +36% vs. our estimates and +19%, +25%, and 34% vs. the Street. Adjusted PAT beat vs. our forecast was driven by lower interest costs and higher associate income.

Sales: 28.8BU (+17% yoy); we’d expected 27.9BU.

Debt and leverage: Gross – Rs584bn (F26: 536bn). Net – Rs476bn (F26: Rs450bn), implies net debt to continuing EBITDA of 2.12x. The board has also approved a fund raising of Rs150bn.

LoAs/PSAs: Signed a 25-year PSA with MSEDCL for supply of 1600MW power. Acquired 180MW Churk thermal power plant and stakes in Jaiprakash Power Ventures and Prayagraj Power.

Construction progress and commissioning guidance: The following projects are planned to be commissioned over F26-29e:

1.32GW Korba Phase II – expected this year;

Mahan Phase-II 1.6GW – scheduled for 1QF28 (88% progress);

Mirzapur Greenfield 1.6GW – commenced execution

JSW Energy Q1 FY27: Cons net profit down 37% at ₹470.97 cr (YoY), up 27% (QoQ)

Revenue up 1% at ₹5,207.13 cr (YoY), up 16% (QoQ)

EBITDA up 3% at ₹2,873.15 cr (YoY), up 28% (QoQ)

Margins 55.18% vs 54.22% (YoY), vs 50.01% (QoQ)

BPCL Q1 FY27: Net loss at -₹3,962.13 cr vs profit of ₹3,191.49 cr (QoQ), vs profit of ₹6,123.93 cr (YoY)

Revenue up 27% at ₹1,51,229.26 cr (QoQ), up 34% (YoY)

EBITDA loss at -₹4,077.42 cr vs profit of ₹10,060.77 cr (QoQ), vs profit of ₹9,663.11 cr (YoY)

Margins at -2.70% vs 8.48% (QoQ), vs 8.59% (YoY)

SRF Limited Q1 FY27: Cons net profit up 76% at ₹758.87 cr (YoY), up 30% (QoQ)

Revenue up 32% at ₹5,033.26 cr (YoY), up 9% (QoQ)

EBITDA up 55% at ₹1,270.63 cr (YoY), up 26% (QoQ)

Margins 25.24% vs 21.22% (YoY), vs 21.83% (QoQ)

Pharma stocks closed sharply lower on Wednesday after the United States proposed steep tariffs on generic drug imports, with the Nifty Pharma Index ending 340 points, or 1.31 per cent, down at 25,752 against a previous close of 26,092. Eighteen of the index’s 20 constituents closed in the red, with trading volume reaching 315.07 lakh shares and a total traded value of...